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Abstract. Fluorinated compounds can exhibit interesting 
biological properties. The importance of these species has 
made that the chemistry of fluorine has experienced a great 
development. On this review, the recent advances on 
asymmetric fluorination reactions promoted by chiral 
hydrogen-bonding-based organocatalysts are discussed. 
Hence, examples using phosphoric acid, carboxylic acid, 
(thio)urea and squaramide derivatives are illustrated. The 
growth of this field is amazing. We have only considered 
pivotal works in which direct fluorination takes place using a 
fluorinating agent, leaving aside the reactions where a 
fluorine atom is incorporated from the beginning as part of 
other reactants. 
Herein, the scarce existing examples on this field of research 
have been compiled.  
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1 Introduction 
Over the last two decades, the chemistry of fluorine 
has drawn much attention in different fields of 
research, such as medicine, agricultural chemistry 
and materials science.[1] In this area, the results 
achieved in asymmetric catalysis deserve special 
mention for the construction of prominent fluorinated 
compounds. The importance of developing new 
asymmetric protocols lies in the interesting scaffolds 
produced through these fluorination reactions, mainly 
involved in the development of new agrochemical[2] 
and pharmaceutical targets (Figure 1).[3]  
Figure 1. Small fluorinated bioactive compounds: I,[4] II,[5] 
III,[6] IV,[7] V[8] and VI.[9] 
Interestingly, it has been found that the 
incorporation of a fluorine atom or a trifluoromethyl 
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aromatic) can alter their physical and chemical 
properties through steric and electronic effects, 
making an overall improvement to the final biological 
properties of the resulting compounds.[10] Focusing on 
asymmetric catalysis, many efforts have been devoted 
to the introduction of new C−F and C−CF3 bonds, 
especially into alkyl chains. 
Since the first asymmetric fluorination protocol 
reported by Togni and coworkers in 2000,[11] many 
other research groups have invested their energies in 
the progress of this field.[12,13] The interest arisen by 
this research area is reflected in the amazing amount 
of works compiled in many pivotal reviews. In the 
field of organocatalysis, a considerable number of 
works have been centered on the chemistry of 
aminocatalysis.[12,14] However, in this review we are 
discussing asymmetric organocatalytic protocols 
focused on hydrogen-bonding-based catalysts, such 
as (thio)ureas,[15] squaramides[16] chiral phosphoric 
acids[17] and chiral carboxylic acids[18] as the most 
representative chiral organocatalysts.[19] Although 
other reviews have covered many examples using 
some of these catalytic structures,[20] we are focusing 
our attention on those works in which direct 
fluorination takes place using a fluorinating agent, 
leaving aside the reactions where a fluorine atom is 
incorporated from the beginning as part of other 
reactants. With these statements in mind, we have 
been able to find a good number of essential 
examples in the literature catalyzed by these selected 
organocatalysts. Additionally, this kind of analysis 
has been overlooked in the literature so far to the best 
of our knowledge. 
Although several strategies have been developed 
for the construction of chiral fluorinated organic 
structures using both nucleophilic[21] and 
electrophilic[22] sources, the catalysts revised in this 
work are mostly involved in electrophilic fluorination 
reactions with 1-chloromethyl-4-fluoro-1,4-
diazoniabicyclo[2.2.2]octane bis(tetrafluoroborates) 
(Selectfluor) or N-fluorobenzenesulfonimide (NFSI) 
(Figure 2). However, some other fluorinating sources 
will be also illustrated and commented on this 
revision. 
 
Figure 2. Commercially available fluorinating sources 
used in this review. 
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2 Chiral anionic phase-transfer 
catalysts  
2.1 Phosphoric acids as precatalysts 
In this field, Toste’s group pioneered the concept 
chiral anion phase-transfer catalysis,[23-25] using 
lipophilic chiral phosphate anion salts as phase-
transfer catalysts. These precatalysts would transport 
insoluble electrophilic fluorinating agents, placed in a 
separate aqueous or solid phase, into organic solution 
in order to finally promote the reaction with different 
substrates. The original catalytic system was formed 
by a chiral phosphoric acid catalyst, such as 2a, and 
Selectfluor 1 (Figure 3).[26] 
 
Figure 3. Chiral anionic phase-transfer catalytic system 
formed by Selectfluor 1 and chiral phosphoric acid 
derivative 2a. 
 
With the main objective of testing the catalytic 
potential of this system, the authors explored the 
efficiency of this chiral anion phase-transfer catalyst 
in the β-fluorination of dihydropyran substrates 3 
(Scheme 1).[26] Therefore, after the optimization of 
the reaction conditions, including the Proton Sponge 
([1,8-bis(dimethylamino)naphthalene] 4) with the 
main aim of generating the anionic catalyst in situ as 
well as to neutralize the acid generated in the course 
of the reaction, spiroketals 5 were obtained with very 
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Scheme 1. Enantioselective fluorocyclization of dihydropyrans 3 giving rise to spiroketals 5. 
Then, the developed fluorocyclization approach 
was extended to other interesting and more 
challenging structures such as dihydronaphthalene 
and chromene substrates 6, leading to the 
corresponding cyclic compounds 7 with very good 
results (Scheme 2). However, in this case a higher 
catalyst loading was required and the use of 




Scheme 2. Enantioselective fluorocyclization of dihydronaphthalenes and chromene 6. 
Remarkably, a plausible reaction mechanism was 
proposed, as depicted in Scheme 3, based on 
additional experimental results and on the exploration 
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Scheme 3. Suggested catalytic cycle based on the 
experimental results. 
In this cycle, two molecules of phosphoric acid 2a 
would generate a chiral ion pair 9 with Selectfluor 1 
by deprotonation and ion exchange, increasing the 
solubility of the active fluorinating agent. Then, the 
alkene 6 would simultaneously suffer a 
fluorocyclization process and the released molecule 
of phosphoric acid 2a would be deprotonated by the 
base present in the reaction medium generating the 
species 8 once again. Two molecules of the anionic 
phosphate 8 would give rise to the chiral ion pair 9 
restarting the catalytic cycle. 
In close relation with this example, the authors also 
applied this idea to the fluorination of enamides 10 
affording α-fluoroimines 11 using a similar catalytic 
system with very good results.[27] In this process, the 
authors went one step further to explain the 
enantioselectivities of the reaction. Therefore, 
founded on the well-known bifunctional role of 
phosphoric acid catalysts, they envisioned the 
plausible formation of an ion pair with the Selectfluor 
reagent 1 through one oxygen atom with concomitant 
activation of the enamide through hydrogen bonding 
with another oxygen atom. The steric hindrance of 
both possibilities would determine the preferred 
disposition of the tetralone in an “open” quadrant, 
with the amide group occupying a “closed” quadrant 
(favored TS, Scheme 4). 
Scheme 4. Reasonable mechanistic attacks to explain the 
stereochemical course of the reaction. 
 
This arrangement would support that the variation 
in the enamide structure does not affect the catalyst-
substrate binding and, consequently, the 
enantioselectivity of the process. The methodology 
tolerated well the substitution in the enamide 
functionality, including substrates with different 
electronic properties (without substitution in the α-
position or even with α-haloenamides). Interestingly, 
only the corresponding 2-methylcyclohexanone-
derived enamide was found as a limitation of the 
process. 
Later on, Toste and co-workers reported an elegant 
approach of “dual” or “cooperative” catalysis,[28] 
using a combination of the chiral phosphoric acid 
catalyst 2a (phase-transfer catalysis) and the amino 
acid ester 13 (enamine catalysis), focused on the 
asymmetric fluorination of α-branched 
cyclohexanones 12 (Scheme 5) leading to quaternary 
fluorine-containing stereocenters.[29] Among the 
catalysts explored, (R)-C8-TRIP 2a and an amino 
ester derivative 13 afforded the desired products 14 
with high enantioselectivities. Moreover, the authors 
found that the level of moisture was affecting the 
final results of this approach. Therefore, Na2CO3·H2O 
with a small amount of water improved the ee from 
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Scheme 5. Asymmetric α-fluorination of 2-substituted cyclohexanones 12. 
Hence, the efficiency of the developed 
methodology was demonstrated by the 
enantioselective fluorination reaction of different 2-
arylcyclohexanones 12 (Scheme 5). Unfortunately, no 
fluorination was observed for 2-alkylcyclohexanones 
under the same reaction conditions, representing a 
limitation of this methodology. In all cases, excellent 
regio- and enantioselectivities were observed with no 
undesired fluorination products. Additionally, 
although the scope is limited to α-branched ketones 
and needs a precise study of the two chiral catalysts 
employed, this work represented a pioneering 
example of aminocatalysis using these substrates, 
which had been previously found unreactive against 
this activation mode.[30] 
The proposed mechanism for this reaction is 
shown in Scheme 6. The reaction is expected to be 
initiated by activation of the ketone in an enamine 
activation cycle, using a protected amino acid 13 as 
organocatalyst. Then, the Selectfluor 1 would 
undergo the activation with the phosphoric acid 2a 
giving rise to the anion phase-transfer catalyst. This 
active species generates a chiral quaternary fluorine 
derivative 14. This was one of the first successful 
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Scheme 6. Proposed catalytic cycle for the enantioselective α-fluorination of ketones 12. 
Another interesting study from the same research 
group was focused on the in situ directing group 
strategy for the fluorination of allylic alcohols 15 
(Scheme 7).[31] The authors addressed this 
challenging task because the use of inactivated or 
weakly activated alkenes was a challenging aim,[32] 
since only π-activated olefins had been previously 
used. 
Therefore, in continuation with their previous 
efforts concerning fluorination of double bonds[33] by 
a carboxamide or phenolic group at the allylic 
position of an alkene as a directing group, they 
investigated this new in situ directing group 
methodology using more fundamental and versatile 
substrates (Scheme 7). The authors combined their 
previous work[33] with a report by Falck´s group 
describing the use of boronic acids to promote a 
formal enantioselective conjugate addition of 
hydroxide,[34] as in situ directing group formed by 
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Scheme 7. Enantioselective fluorination of allylic alcohols 
15 using phosphoric acid 2b. 
During the screening of the optimized reaction 
conditions, p-tolylboronic acid 16 was found to be 
particularly effective as the boronic acid source. 
Moreover, the elimination of water was necessary to 
shift the equilibrium in favor of the boronic ester 
formation. Indeed, among the different tested chiral 
phosphoric acids, phosphoric acid 2b ((S)-AdDIP) 
was the best catalyst and Na2HPO4 was chosen as the 
best base to regenerate the chiral anion phase-transfer 
catalyst. Final fluorinated alcohols 17 were obtained 
in excellent yields and enantioselectivities from 
inactivated but synthetically versatile alcohols 15. In 
fact, the process tolerated different substitutions of 
the alcohol 15. 
Moreover, based on more experimental 
information and kinetic isotope effect studies, a 
plausible concerted mechanism was suggested to 
explain the results obtained (Scheme 8). 
 
 
Scheme 8. Proposed concerted mechanism for the boronic 
acid-mediated enantioselective fluorination−elimination 
reaction of allylic alcohols 15. 
The authors proposed that both C−F bond 
formation and C−H bond cleavage occurred in a 
concerted enantio-determining transition state (TS, 
Scheme 8). Moreover, it was suggested that the 
cleavage of the C−H bond played an unusually 
important role in the asymmetric induction of this 
process. 
More recently, Toste’s group demonstrated that a 
double axially chiral anionic phase-transfer 2c was 
able to promote the regioselective asymmetric 
fluorocyclization reaction of 18 under mild reaction 
conditions (Scheme 9).[35,36] This idea was founded on 
previous enamide fluorination methodologies 
developed by the same group.[27,37] 
With this interesting idea in mind, a protocol for 
the asymmetric synthesis of two families of 
pharmaceutically privileged scaffolds 19, 
dihydroquinazolone and benzooxazinone derivatives, 
was developed. Different substitutions of the enamide 
scaffold 18 reacted with Selecflour 1 in the presence 
of Na2CO3 at room temperature, affording a broad 
scope of products with moderate to good yields and 
high enantioselectivities (Scheme 9). Furthermore, 
unsymmetrically substituted enamides were also 
employed and the expected products were obtained 
with excellent diastereoselectivities and moderate 
enantioselectivities (>20:1 dr, 57-87% ee). 
 
 
Scheme 9. Enantioselective synthesis of 
fluoro−dihydroquinazolones and –benzooxazinones 19. 
In this field, this research group has put forth great 
effort into the development of other successful 
fluorination processes and many other pivotal 
examples have been reported.[38] 
 
2.2 Carboxylic acids as precatalysts 
Based on the previous work reported by Toste and 
co-workers, Hamashima’s group described the first 
successful example of a highly enantioselective 
fluorolactonization process catalyzed by a 
bifunctional organocatalyst derived from carboxylic 
acid, as a novel family of phase-transfer catalysts 
(Scheme 10).[39,40] The bifunctional catalyst 21 was 
designed on the base of two important considerations: 
1) to efficiently transfer the fluorinated agent 1 into 
the liquid phase, and 2) to undergo an associative 
interaction with the anionic substrate with the aim of 
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was built with a carboxylate group as an anionic 
moiety to form an ion pair with 1 and a OH group as 




Scheme 10. Scope of the enantioselective 
fluorolactonization reaction catalyzed by bifunctional 
catalyst 21. 
Fluorolactonization reaction using ene-carboxylic 
acids 20 worked smoothly giving rise to the 
corresponding fluorinated isobenzofuranones 22 in 
good yields (up to 99%) and with high to excellent 
enantioselectivities (up to 94%). 
Additional experimental results using different 
structural analogues of catalyst 21 supported the 
necessity of both moieties (the carboxylate  anion and 
the OH group) to provide the best chiral induction. 
The experimental results also agreed with the 
bifunctional role of the catalyst proposed by the 
authors, keeping in a concomitant coordination the 
substrate 20 as anion and the cationic fluorinating 
reagent in a chiral cavity. 
Based on these initial results, the authors 
hypothesized that the cooperative action of two 
carboxylate anions situated with an appropriate 
distance in the precatalyst structure should provide 
higher reaction efficiency. For this purpose, the 
authors designed and synthesized a number of 
dicarboxylic acid precatalysts (Figure 4).[41,42]  
 
 
Figure 4. Dicarboxylic acid derivatives 24. 
 
Then, the authors explored the efficiency of such 
structures in the unprecedented 6-endo 
fluorocyclization reaction of allylic amides described 
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Scheme 12. Scope of 6-endo fluorocyclization reaction using acyclic allylic amides 26. 
 
 
Therefore, the authors were able to perform 6-endo 
fluorocyclization reactions with high 
enantioselectivities (up to 99%) and the new 
developed family of dianionic phase transfer catalysts 
could efficiently control the fluorine delivery step for 
this variety of substrates. 
Using the same dicarboxylic acid precatalysts 24a 
and more recently, Hamashima’s group has 
developed two additional works. One of them is 
based on the development of an enantioselective 5-
exo-fluorocyclization of ene-oxime compounds[43] 
and the most recent one is an asymmetric 
dearomative fluorination of 2-naphthols.[44] In all 
cases, the catalytic species is formed by a 
dicarboxylate dianion generated in situ by 
deprotonation of 24 and Selectfluor (1), allowing the 
transfer of 1 from the solid phase to the liquid phase 
giving rise to a chiral Selectfluor species as described 
in Figure 5.  
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3 (Thio)urea derivatives as 
organocatalysts for asymmetric 
fluorination reactions 
3.1 Chiral thiourea catalysts 
In the field of thiourea organocatalysts,[45] Shibata 
and coworkers pioneered an organocatalytic 
procedure to fluoromethylate aldehydes.[46] Among 
the different strategies to achieve asymmetric 
fluorination, 2-fluoro-1,3-benzodithiole-1,1,3,3-
tetraoxide (29, FBDT) was selected as the source of 
fluorine, based on their previous knowledge using 
this substance.[47] The authors envisioned that a 
tandem between a chiral thiourea 30 and a titanium 
complex as a Lewis acid could activate the aldehyde, 




Scheme 13. Organocatalytic asymmetric procedure developed by Shibata and coworkers. 
On the first step of the reaction, the addition of 
FBDT 29 to the aldehydes 28 promoted by the 
cinchona-thiourea-Ti(OiPr)4 tandem would take 
place. The authors suggested that the extra hydrogen 
bond created by the –OH group in the quinoline 
moiety improves the selectivity of the process. This 
way, they obtained a scope of 13 compounds 31 
using aromatic and aliphatic aldehydes 28 with 
moderate to good yields (73-91%) and 
enantioselectivities (32-91%). However, aliphatic 
aldehydes seemed to produce lower selectivities than 
their aromatic counterparts. Furthermore, to test their 
global hypothesis, the authors performed a CS bond 
cleavage mediated by SmI2 to obtain a final 
fluoromethylated alcohol 30 with a 73% yield. 
Finally, a derivatization process took place to obtain a 
single crystal and the measurement of the absolute 
configuration of the products afforded the enantiomer 
R. To the best of our knowledge, this is the 
pioneering and only example of a fluoromethylation 
reaction promoted by non-covalent 
organocatalysis.[48] Although the authors did not 
clarify completely the reaction mechanism, they 
successfully proved that hydrogen bonding is of 
utmost importance to enhance the selectivity of the 
process, obtaining the desired products 31 with good 
values of yield and trifluoromethylthiolation. 
Focusing now on electrophilic monofluorination 
reactions, Hu and coworkers reported in 2012 the 
pioneering example of a cinchona-thiourea derivative 
capable of catalyzing the enantioselective fluorination 
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Scheme 14. Thiourea-catalyzed enantioselective fluorination of β-ketoesters 33-36. 
The reaction was conducted with indanone 33, 
tetralone 34 and cyclopentanone 35 carboxylate 
derivatives and with acyclic β-ketoesters 36 as the 
model substrates. These compounds have been 
previously involved in other fluorination reactions 
with different catalytic systems.[50] N-
Fluorodibenzenesulfonimide (38, NFSI) was used as 
a fluorine source and the process was promoted by 
the cinchona-thiourea derivative 37 using 4-dimethyl 
aminopyridine (DMAP) as an additive. The reaction 
proceeded smoothly in most cases. However, no or 
very low selectivity was observed when an extremely 
bulky substituent was placed on the ester and in the 
cases where a tetralone derivative 34 was used. On 
the other hand, acyclic substrates 36 had high 
variability in their results. Overall, the reaction 
produced a high number of examples with good 
diversity, moderate to excellent yields (41-96%), and 
no to excellent enantioselectivities (0->99%).  
On the base of all experimental results, the authors 
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Scheme 15. Reaction mechanism proposed for the enantioselective fluorination of β-ketoesters 33-36 catalyzed by 
thiourea 37.[51] 
As is shown, first the basic center of the thiourea 
37 would activate the β-ketoester 33. Then, NFSI 38 
would be activated in the acidic site of the thiourea, 
making the reaction to take place. Then, the basic 
additive would take the leftover proton to stabilize 
the dibenzenesulfonimidate, closing the cycle. The 
authors did not provide further insight into the 
absolute configuration of the products. 
Ma and coworkers developed, in two related works 
in 2012 and 2013, a one-pot sequential 1,4-
addition/dearomative-fluorination transformation.[52] 
This methodology proceeded with the addition of 
pyrazolone 43 or isoxazolone 47 derivatives to 
nitroalquenes 44 followed by the fluorination with 
NFSI 38. On the first methodology, the authors used 
the thiourea derivative 45 to catalyze the full process 
based on previous works concerning thiourea-
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On the first step of the process, the trans-β-
nitrostyrene derivative 44 would be activated by the 
thiourea 45 and the 1,4-addition of the pyrazolone 
derivative 43 would take place. Then, the fluorination 
with NFSI 38 would be carried out. Moreover, a 
weak Brønsted acid improved the results, though a 
40% loading was needed. The protocol provided a 
broad scope of products 46, including aliphatic 
examples, achieving good to excellent yields (72-
95%), moderate to excellent diastereoselectivities 
(73:27->99:1) and good to excellent 
enantioselectivities of the major isomer (87-98%). 
In the second work, the developed procedure is 
very similar to the first one. In this case, the chiral 
thiourea 48 catalyzed the addition of the isoxazolone 
derivative 47 (Scheme 17). 
 
 
Scheme 17. One-pot synthesis of the fluorinated isoxazolone derivatives 49 promoted by the thiourea 48. 
The main differences with the previous work were 
a better overall atom economy, lower catalyst loading 
(5 - 10 mol%), different solvent (Et2O - toluene) and 
the absence of aliphatic examples. Interestingly, the 
results were improved by the addition of a weak 
Brønsted base (Na2CO3) instead of an acid 
(PhCO2H). With this setup, this approach provided a 
similar number of products with better overall yields 
(83-94%) and diastereomeric ratio (97:3->99:1), but 
slightly worse enantioselectivities (64-92%). 
Due to the similarity of the reactions, only the key 




Figure 6. 1,4-Addition and fluorination steps of the 
processes developed by Ma and coworkers.[54] A = 
pyrazolone derivatives 46. B = isoxazolone derivatives 49. 
Section A explains the important role played by the 
Brønsted acid additive. First, it would protonate the 
basic moiety of the catalyst to establish a hydrogen 
bond with the pyrazolone 43. Then, the counterion 
would force a tautomerization from the keto to the 
enolic form of the pyrazolone derivative 43 for the 
addition to be carried out. The same tautomerization 
occurs to facilitate the fluorination step. As depicted 
in section B, despite the additive not taking part in the 
first step, it was essential in the fluorination step to 
deprotonate the isoxazolone 47 and to promote the 
attack to the fluorine source. 
These two works are an interesting example of the 
cooperative behavior between a non-covalent 
organocatalyst and its potential additives, being basic 
or acid. In spite of the complexity of the system 
involved, the developed procedures led to the desired 
products with very good results. 
The last thiourea catalyzed fluorination process 
was reported by Yi, Zhang and coworkers in 2013.[55] 
They developed a one-pot fluorination and 
asymmetric Michael addition promoted by recyclable 
fluorinated organocatalyst 50. In this work, the 
authors explored the thiourea catalyst 50 bearing a 
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Scheme 18. Enantioselective one-pot asymmetric Michael addition and fluorination of β-ketoesters 36. 
As the fluorinating agent, the authors chose 
Selectfluor 1. They used a series of β-ketoesters 36 
and explored their Michael addition to nitroalkenes 
44, chalcone 52 and maleimide 54 derivatives and 
further fluorination of the resulting intermediates. 
The reaction with nitroalkenes 44 proceeded with 
good to excellent yields (87-96%), moderate to good 
diastereoselectivities (2:1-9:1) and moderate to 
excellent enantiomeric excesses (57-96%) to obtain 
seven different products 51. However, when a 
chalcone derivative 52 was used as a Michael 
acceptor the results were a bit worse (4 examples, 42-
71% yield, 2:1-4:1 dr, 8-37% ee), even using higher 
catalyst loadings (20-50 mol%) and adding Cs2CO3 
as an additive. In contrast, the fluorination of the β-
ketoesters 36 followed by their addition to the 
maleimide derivatives 54 produced 8 different 
examples with excellent yields (90-98%), 
diastereoselectivities (>20:1) and good to excellent 
enantioselectivities of the major isomer (77-94%). 
Moreover, as expected, the recovery of the catalyst 
50 by fluorous solid-phase extraction (F-SPE)[56] was 
successful. Additionally, the use of the recovered 
catalyst in a further process yielded the same results 
as before. This fact means that no appreciable 
poisoning of the catalyst took place, at least, in 2 
cycles of reaction. 
3.2 Chiral urea catalysts 
Generally, urea derivatives are not explored as 
extensively as their thiourea counterparts.[57] This fact 
could be explained by the generally superior 
performance of thioureas because of their higher 
acidity[58] and lesser self-aggregation.[59] Still, there is 
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catalyzing direct asymmetric fluorination reactions in 
the literature. 
Firstly, in 2014, Waser and coworkers developed 
the pioneering example in this field, performing the 
fluorination of indanone 33, tetralone 34a and 
cyclopentanone 35a carboxylate derivatives, using 
NFSI 38 as the source of fluorine (Scheme 19).[60] 
 
 
Scheme 19. Enantioselective fluorination of β-ketoester 33-35 catalyzed by chiral urea 56. 
The authors successfully used the urea derivative 
56 to obtain a broad scope of products with moderate 
to excellent yields (52-96%) and good to very good 
enantioselectivities (85:15-93:7). However, the use of 
the tetralone 34a and cyclopentanone 35a derivatives 
afforded slightly lower values (73% yield 87:13 er 
and 66% yield 89:11 er respectively). It should be 
highlighted that the process included aqueous K3PO4 
as an additive. Furthermore, the authors proposed a 




Figure 7. Transition state proposed to explain the absolute 
configuration observed. 
Following the proposed mechanism, the amine of 
the catalyst would drive the attack to the NFSI 38 
fixed in the acidic site of the urea by the Re face, 
affording the absolute R configuration observed in all 
final products. In addition to that, the proposal 
showed the importance of the catalyst-enolate 
electrostatic interaction and this statement was 
supported with two supplementary experiments with 
a catalyst without the urea moiety 57 and without the 
charged amine 58, giving rise to poorer selectivities 
(51:49 and 59:41 er respectively). 
Based on the previous report,[60] Shi and coworkers 
developed in 2016 a new protocol in which they were 
able to support a similar catalyst 59 on polyethylene 
glycol (PEG). This approach makes it easy to recover 
the catalyst by precipitation in diethyl eter,[61] still 
being able to operate in homogeneous conditions. 
This catalyst was also used to carry out the 
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Scheme 20. Enantioselective fluorination of β-ketoesters 33-36 catalyzed by the supported urea catalyst 59. 
Under these conditions, the authors were able to 
perform the reaction using NFSI 38 as the fluorine 
source with indanone 33, tetralone 34a and 
cyclopentanone 35a carboxylate derivatives and the 
β-ketoester 36b. Furthermore, they were able to halve 
the catalyst loading used before to achieve moderate 
to excellent yields (39-96%) and moderate to good 
selectivities (23-85%). However, using the β-
ketoester 36b produced a lower yield (39%) and 
enantiomeric excess (23%). Additionally, the authors 
proposed that the absolute configuration of the 
products would be R by comparison with previously 
reported optical rotation values and retention 
times.[63] 
In 2018, Jiang, Yeung and coworkers developed a 
method to perform the enantioselective fluorination 




Scheme 21. Enantioselective fluorination of oxindole derivatives 60. 
 
The reaction proceeded smoothly using urea 61 as 
the catalyst and NFSI 38 as the fluorine source in the 
presence of Na2CO3. Differently substituted oxindole 
derivatives 60 underwent the catalysis, obtaining 30 
examples with moderate to excellent yields (51-99%) 
and selectivities (82:18-97:3). Both N-protected and 
unprotected oxindole derivatives (which had been 
less explored in the past)[65] could be used in this 
process with no drawbacks. However, unprotected 













Advanced Synthesis & Catalysis
This article is protected by copyright. All rights reserved.
 19 
times and 3-aryl substituted ones yielded to the worst 
results in terms of enantioselectivity (82:18). 
Furthermore, the authors proposed the following 




Scheme 22. Reaction mechanism proposed for the enantioselective fluorination of oxindole derivatives 60 catalyzed by 
urea 61. 
 
In the first step, catalyst 61 would subtract the 
fluorine atom from the NFSI molecule. Then, the 
oxindole derivative would coordinate with the urea 
moiety, and the remaining benzenesulfonimidate 
would launch the nucleophilic attack to produce the 
enantioselective fluorination. It is worth noting that 
urea 61 lacks a traditional electron-withdrawing 
group such as 3,5-bis(trifluoromethyl)phenyl; instead, 
the authors speculated that having an adamantly 
group would provide an optimal steric environment 
for the process to take place. In addition to that, using 
single-crystal X-ray diffraction, the authors were able 
to assign the absolute configuration of the products, 
being it S. 
Lastly, Gouverneur and coworkers reported, in 
three consecutive works in 2018, 2019 and 2020, a 
new prospect using solid fluoride salts as the 
nucleophilic fluorine source. Since electrophilic 
fluorination reagents are predominant in this field as 
shown in this review, these are the only examples of 
nucleophilic fluorination using this kind of catalysts, 
given that the use of such reactants is highly 
problematic. Moreover, the authors envisioned that a 
urea derivative should be able to coordinate the F- ion, 
taking it into an organic solution from the solid 
source. To prove the previous hypothesis, they 
investigated the use of a urea-fluoride complex to 
achieve a nucleophilic substitution reaction with alkyl 
bromides.[66] 
In the first reported work, β-bromosulfides 63, as 
reactants, and solid CsF, as the fluorine source, were 
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Scheme 23. Enantioselective nucleophilic fluorination of 
β-bromosulfides 63. 
The reaction proceeded smoothly in 1,2-
difluorobenzene to afford a broad scope of products 
65 with moderate to excellent yields (53-98%) and 
good to excellent selectivities (91:9-97:3). 
In the second crucial work, β-haloamines 66 and 













Scheme 24. Enantioselective nucleophilic fluorination of β-haloamines 66 and 67. 
 
In this work, the procedure was adapted using a 
different catalyst 68, CHCl3 or α,α,α-trifluorotoluene 
as solvents and either solid KF or CsF as fluorine 
sources in two twin methodologies. With these two 
catalytic systems, the authors were capable of 
obtaining a huge number of compounds with similar 
results, with moderate to excellent yields (A = 56-
92%; B = 52-96%) and selectivities (A = 74.5:25.5-
96:4; B = 75:25-97.5:2.5). 
In addition to that, the authors explained why β-
bromosulfides 63 and β-haloamines 66 and 67 were 
selected as substrates to explore the reaction. These 
works were inspired by the ring opening reactions of 
aziridinium and episulfonium salts previously 
developed by Jacobsen and Toste.[69] These studies 
came along with a mechanistic proposal supported by 
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Scheme 25. Mechanistic proposal to explain the nucleophilic fluorination reactions. First work (mechanism A) and second 
one (mechanism B). 
 
In these proposals, the first one (A) being a 
racemic approach, the key step was the ability of the 
β-bromosulfides 63 and β-haloamines 66 and 67 to 
form episulfonium and aziridinium ions, respectively, 
to receive a further nucleophilic additions. The urea 
catalysts 64 or 68 would subtract an F- ion from the 
solid phase forming a complex and entering the 
organic phase. After that, the β-bromosulfides 63 or 
β-haloamines 66 and 67 would enter the cycle and 
undergo the diastereoselective nucleophilic addition 
to yield the desired products. Furthermore, the 
authors gave an S,S absolute configuration for the 
products based on single-crystal X-ray diffraction. 
Lastly, in their most recent methodology, the 
authors explored the desymmetrization of achiral 
azetidinium salts, inspired by a previous work of Sun 
and coworkers.[70] This approach could produce γ-
fluoroamines, an important target in medicinal 
chemistry.[71] The scope of this interesting reaction is 
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Scheme 26. Desymmetrization of azetidinium salts 71. 
 
The reaction was driven by urea 64, using CsF as 
the fluorine source to produce the aperture of the 
racemic azetidinium salts 71. In a first exploration of 
the ideal substituents, the authors found that the 
benzhydryl group was decisive to obtain good results. 
Therefore, modifying other groups, the authors were 
able to obtain 33 examples with moderate to excellent 
yields (51-99%) and good to excellent selectivities 
(82.5:17.5-97:3 er). Nevertheless, alkylated 
compounds at position 3 and those with 
heteroaromatic substituents were slightly less 
successful. To conclude, using single-crystal X-ray 
diffraction, the authors were able to assign the 
absolute configuration S to the products. 
4 Chiral Squaramides as 
Organocatalysts for Asymmetric 
Fluorination Reactions 
Squaramides have gained great relevance in non-
covalent organocatalysis, generally outperforming 
urea, thiourea and guanidine derivatives. They are 
capable of establishing stronger hydrogen bonds, with 
better angles to activate carbonyl groups and a lesser 
tendency to form aggregates than their 
predecessors.[16] Due to these properties, squaramide 
derivatives have been also explored as suitable 
catalysts in direct asymmetric fluorination 
reactions.[73] 
In 2015, the first example of this kind of procedure 
was reported by Lin, Duan and coworkers. Inspired 
by previous procedures in which urea and thiourea 
derivatives were used (as described in section 3), they 
envisioned that the squaramide catalyst 73 could 
carry out the asymmetric fluorination reaction of β-
ketoesters 33 giving rise to better results (Scheme 
27).[74] 
Scheme 27. Asymmetric fluorination of β-ketoesters 33 
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The reaction selected to test their hypothesis was 
the asymmetric fluorination of indanone carboxylate 
derivatives 33 using NFSI 38 as the source of fluorine. 
The reaction was performed in Et2O using aqueous 
K2CO3 as an additive to form the corresponding 
enolate from the selected β-ketoester 33. This 
approach allowed them to obtain some different 
examples with excellent yields (91-97%) and 
moderate to good selectivities (56-76%). It is 
noteworthy that the authors suggested a plausible 
mechanism, explaining the absolute configuration of 
the products obtained with this catalytic system 
(Figure 8). 
 
Figure 8. Proposed enantioselective attack of β-ketoesters 
33 catalyzed by phase transfer squaramide 73.[75] 
In this proposal, the basic additive would form an 
enolate from the β-ketoester 33, enabling its 
electrostatic union with the quaternary amine on the 
catalyst. Hence, an attack from the Si face of the 
enolate would be driven by the catalyst to the 
electrophilic F donor substrate (NFSI, 38) fixed in the 
acid moiety, giving rise to the corresponding products 
39 with an (S) configuration. 
In 2015, Wang and coworkers reported another 
example based on the use of squaramide derivatives 
75 (Scheme 28, A).[76] In 2018, the same group 
developed another work in which the authors 
supported such catalysts on carbon nanosheets 
(Scheme 28, B).[77] 
 
Scheme 28. Enantioselective fluorination of isatin and pyrazolone derivatives 74 and 43. 
The selected reactants for this work were isatin 74 
and pyrazolone 43 derivatives, using NFSI 38 as the 
fluorine source. The authors developed a one-pot 
protocol in which firstly the enantioselective addition 
of the pyrazolone 43 would take place, creating an 
adequate environment for the fluorination to be 
carried out. It is noteworthy that this system needed 
K2CO3 as an additive to work. Furthermore, the 
catalyst loading (0.5 mol %) is one of the lowest used 
in non-covalent organocatalysis.[78] With this 
methodology, the authors could obtain a broad scope 
of products with very good to excellent yields (88-
96 %), high diastereoselectivities (>20:1) and 
excellent enantiomeric excesses for the major isomer 
(95->99 %). In addition to that, the authors gave an 
absolute configuration for the products of (3S,4´R) 
based on single-crystal X-ray diffraction. 
Afterwards, the same group developed a procedure 
to attach the previous catalyst 75 to porous carbon 
nanosheets (PCN).[79] This material is known for its 
macropores, cavities with the potential to transport 
different substances or to be used as catalytic 
microreactors. Hence, after the immobilization 
procedure, the same reaction was performed, 
achieving similar results to the ones before with the 
only drawbacks being higher catalyst loading, a 
narrower scope of products and a slightly worse atom 
economy. However, this setup made the catalyst 
recoverable and the authors were able to make a 
continuous flow system to perform the reaction. The 
system had a productivity of 0.7 mmol h-1 g-1 
obtaining the product with an excellent yield (91%) 
and very good selectivity (88%) with no appreciable 
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The last example was reported by Du and 
coworkers in 2017. This work is the only asymmetric 
organocatalytic example, using (thio)urea or 
squaramide derivatives, of a trifluoromethylthiolation 
reaction separated from the predominant 
monofluorination reactions (Scheme 29).[80] 
 
 
Scheme 29. First trifluoromethylthiolation reaction organocatalyzed by squaramide 80. 
In the first procedure, the authors investigated the 
reaction between the benzylidenecyclopentanone 
carboxylate derivative 78 and the 
mercaptobenzaldehyde derivative 77. After the first 
step, they explored different trifluoromethylthiolating 
reagents,[81] finally selecting 1-
(trifluoromethylthio)pyrrolidine-2,5-dione 79 as the 
best option. With this setup, the authors were able to 
obtain 16 different products with moderate to very 
good yields (58-85%) and diastereoselectivities (2:1-
15:1) and very good to excellent enantiomeric 
excesses (87->99%). Electron-withdrawing groups in 
the benzylidene position (Ar) seemed to produce 
lower yields, while the opposite happens with 
electron-donating groups.  
In the second protocol, the authors made use of the 
cyclohexenone carboxylate derivative 79 to expand 
the scope of the methodology, obtaining excellent 
yields (92%) and enantioselectivities (90%). 
5 Summary and Outlook 
This review covers all existent examples involving 
chiral phosphoric and carboxylic acids, (thio)urea and 
squaramide derivatives in fluorination reactions, 
where hydrogen bond interactions are the main 
activation tool. The use of organocatalysts in 
fluorination reactions is still growing, but in this work 
the different catalysts and approaches reported in this 
scarcely developed subarea of research are shown and 
discussed. 
Most of the examples involve electrophilic 
fluorination reactions using 1-chloromethyl-4-fluoro-
1,4-diazoniabicyclo[2.2.2]octane 
bis(tetrafluoroborates) (Selectfluor) or N-
fluorobenzenesulfonimide (NFSI) as the source of 
fluorine for the production of interesting fluorinated 
compounds. There is still plenty of room for new 
organocatalysts or improvements to the known ones 
and new fluorinated reagents to be discovered.   
This review is also a small tribute to the efforts and 
the crucial contributions made by all authors. We 
hope that this work encourages researchers working 
with hydrogen-bonding-based catalysts to expand the 
chemistry of fluorine in the next future. This will be 
vital for the progress of this field of high interest in 
the pharmaceutical industry. 
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